Validation of flavivirus infectious clones carrying fluorescent markers for antiviral drug screening and replication studies

Archive ouverte

Cherkashchenko, Liubov | Gros, Nathalie | Trausch, Alice | Neyret, Aymeric | Hénaut, Mathilde | Dubois, Gregor | Villeneuve, Matthieu | Chable-Bessia, Christine | Lyonnais, Sébastien | Merits, Andres | Muriaux, Delphine

Edité par CCSD ; Frontiers Media -

International audience. Flaviviruses have emerged as major arthropod-transmitted pathogens and represent an increasing public health problem worldwide. High-throughput screening can be facilitated using viruses that easily express detectable marker proteins. Therefore, developing molecular tools, such as reporter-carrying versions of flaviviruses, for studying viral replication and screening antiviral compounds represents a top priority. However, the engineering of flaviviruses carrying either fluorescent or luminescent reporters remains challenging due to the genetic instability caused by marker insertion; therefore, new approaches to overcome these limitations are needed. Here, we describe reverse genetic methods that include the design and validation of infectious clones of Zika, Kunjin, and Dengue viruses harboring different reporter genes for infection, rescue, imaging, and morphology using super-resolution microscopy. It was observed that different flavivirus constructs with identical designs displayed strikingly different genetic stabilities, and corresponding virions resembled wild-type virus particles in shape and size. A successful strategy was assessed to increase the stability of rescued reporter virus and permit antiviral drug screening based on quantitative automated fluorescence microscopy and replication studies.

Consulter en ligne

Suggestions

Du même auteur

Low selectivity index of ivermectin and macrocyclic lactones on SARS-CoV2 replication in vitro argues against their therapeutic use for COVID-19

Archive ouverte | Chable-Bessia, Christine | CCSD

Abstract There are very limited antiviral therapeutic options for coronavirus infections, therefore global drug re-purposing efforts are paramount to identify available compounds that could provide clinical benefits to patients wi...

Atomic force microscopy analysis of native infectious and inactivated SARS-CoV-2 virions

Archive ouverte | Lyonnais, Sébastien | CCSD

International audience. Abstract SARS-CoV-2 is an enveloped virus responsible for the Coronavirus Disease 2019 (COVID-19) pandemic. Here, single viruses were analyzed by atomic force microscopy (AFM) operating direc...

The FDA-approved drug Auranofin has a dual inhibitory effect on SARS-CoV-2 entry and NF-κB signaling

Archive ouverte | Laplantine, Emmanuel | CCSD

International audience. Patients with severe COVID-19 show an altered immune response that fails to control the viral spread and suffer from exacerbated inflammatory response, which eventually can lead to death. A m...

Chargement des enrichissements...